CNS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cohen & Steers Inc (CNS) is not a strong buy at the moment for a beginner investor with a long-term strategy. The company's recent financial performance shows declining revenue, net income, and EPS. Analysts have downgraded the stock with a reduced price target, citing a challenging macro environment. Additionally, the recent decline in AUM and lack of significant positive catalysts make this stock less attractive for immediate investment. While technical indicators like MACD and RSI are neutral to slightly positive, they do not outweigh the broader concerns.
The MACD histogram is positive and expanding, indicating mild bullish momentum. RSI is at 65.377, which is neutral. Moving averages are converging, showing no clear trend. Key support and resistance levels are at S1: 60.96, Pivot: 62.74, R1: 64.52, and R2: 65.62. Overall, the technical indicators are neutral to slightly bullish but do not strongly support a buy decision.
NULL identified. The MACD shows mild bullish momentum, but this is not a strong enough catalyst for a buy decision.
Decline in AUM to $93.1 billion due to market depreciation.
Analysts have downgraded the stock with a reduced price target, citing a challenging macro environment.
Financial performance in Q4 2025 showed significant declines in revenue (-5.55%), net income (-23.88%), and EPS (-23.60%).
In Q4 2025, revenue dropped to $115.89 million (-5.55% YoY), net income fell to $34.88 million (-23.88% YoY), and EPS decreased to $0.68 (-23.60% YoY). Gross margin remained unchanged. These figures indicate a weakening financial position.
BofA downgraded the stock to Underperform and reduced the price target from $64 to $53, citing a challenging macro environment and weak Q1 2026 expectations for the asset management sector.
